GlassScriptPhysician profile
Michelle M Nash
NPI 1174853154
$2,655.64
in general payments reported to CMS, 2019-2025
17 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $312 · 2022: $547 · 2023: $649 · 2024: $617 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,796.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,054.99 | 2021-2025 | |
| Amgen INC. | $553.20 | 2021-2025 | Enbrel, Otezla, Otezla |
| Glaxosmithkline, LLC. | $188.46 | 2022-2025 | Benlysta |
| Ucb, INC. | $177.29 | 2022-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $128.61 | 2021-2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $118.28 | 2023-2025 | Orencia |
| Horizon Therapeutics Plc | $90.25 | 2021-2023 | Krystexxa |
| Lilly USA, LLC | $87.39 | 2021-2024 | Taltz |
| Novartis Pharmaceuticals Corporation | $55.63 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $34.28 | 2022-2023 | |
| Pfizer INC. | $31.90 | 2024-2025 | |
| Sandoz INC. | $28.48 | 2024 | Hyrimoz |
| Octapharma USA, INC. | $25.70 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.57 | 2023 | Cyltezo |
| Emd Serono, INC. | $20.40 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $20.08 | 2024 | Idacio |
| Genzyme Corporation | $19.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.